Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa

In this study, we examined the in vitro effect of tobramycin-efflux pump inhibitor (TOB-EPI) conjugates in combinations with fluoroquinolones, rifampicin and fosfomycin on the growth of multi-drug resistant (MDR) and extremely-drug resistant (XDR) Pseudomonas aeruginosa. The TOB-EPI conjugates inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xuan, Domalaon, Ronald, Lyu, Yinfeng, Zhanel, George G., Schweizer, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069439/
https://www.ncbi.nlm.nih.gov/pubmed/29932132
http://dx.doi.org/10.3390/jcm7070158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069439/
https://www.ncbi.nlm.nih.gov/pubmed/29932132
http://dx.doi.org/10.3390/jcm7070158

Ejemplares similares